To Advance Collaboration in Precision Medicine, Bio-IT World Opens Global Event to the Public April 16-18, 2019
BOSTON--(BUSINESS WIRE)--Mar 25, 2019--In the spirit of open collaboration, the world’s premier bio-IT conference is inviting the community to experience and contribute to the future of precision medicine—together.
With a focus on AI, data science and other “data-driven” technologies that are advancing biomedical research, drug discovery and healthcare, the Bio-IT World Conference & Expo ’19 will attract more than 3,400 participants to the Seaport World Trade Center in Boston from April 16-18. The public will have the chance to meet and share research/ideas with leading life sciences, pharmaceutical, clinical, healthcare, informatics and technology experts. Among the content that’s open to the community with an Exhibit Hall & Keynote Session Pass:
- Plenary sessions on Open Science, AI in Practice, and Converting Data to Insights with Sage Bionetworks, the Broad Institute of Harvard and MIT, GNS Healthcare, Vivid Biosciences, and Pfizer
- 1:1 Q&As with the Plenary Speakers from these organizations
- A full Exhibit Hall with 185+ companies and technology innovators
- Conference sessions on Edge applications like the IoT (where people and things connect with the network)
- Solutions Theater presentations from IBM, RStudio Inc., Pharma Intelligence, WuXi NextCODE, QIAGEN and Spectra Logic
- An onsite FAIR Data Hackathon, innovation and open access awards, and 50+ technical posters
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Preclinical Congress, The Bioprocessing Summit, Next Generation Dx Summit, Immuno-Oncology Summit, and Discovery on Target. CHI’s portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Bio-IT World, Clinical Research News, and Diagnostics World.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190325005140/en/
CONTACT: Contact Dawn Ringel
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Cambridge Healthtech Institute
Copyright Business Wire 2019.
PUB: 03/25/2019 10:00 AM/DISC: 03/25/2019 10:01 AM